Yingying Qu

机构：Shanghai Jiao Tong University, Institute of Immunology, Shanghai First People's Hospital, State Key Laboratory of Oncogene and Related Genes, Shanghai Children's Hospital · ORCID：0009-0003-5302-3759

发表论文 2 篇 · 总被引 28 次 · h-index 2

代表论文

• Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors (2018 · European Journal of Medicinal Chemistry · 被引 24)
• MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy (2025 · The Journal of Experimental Medicine · 被引 4)